Atlas Trials

Third-line Treatment of Gefitinib in NSCLC Patients

Clinical trial NCT01933347 · COMPLETED

Trial details

NCT number
NCT01933347
Sponsor
Guangdong Association of Clinical Trials
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Non Small Cell Lung Cancer
Start date
2014-04-07
Primary completion
2017-04-10
Enrollment
46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.